Log In
Print
BCIQ
Print
Print this Print this
 

GS-9973

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOral spleen tyrosine kinase (SYK) inhibitor
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionSyk kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today